Biogen
Trade Biogen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
Stock Snapshot
With a market cap of 25.55B, Biogen(BIIB) trades at $174.12. The stock has a price-to-earnings ratio of 15.79.
As of 2026-01-27, Biogen(BIIB) stock has fluctuated between $172.23 and $176.14. The current price stands at $174.12, placing the stock +1.1% above today's low and -1.1% off the high.
The Biogen(BIIB)'s current trading volume is 725.95K, compared to an average daily volume of 1.65M.
During the past year, Biogen(BIIB) stock moved between $110.04 at its lowest and $190.20 at its peak.
During the past year, Biogen(BIIB) stock moved between $110.04 at its lowest and $190.20 at its peak.
BIIB News
Citi raised the firm’s price target on Biogen (BIIB) to $185 from $180 and keeps a Neutral rating on the shares. The firm adjusted targets in the biopharma grou...
Eisai (ESAIY) and Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has accepted for review Eisai’s Supplemental Biologics License Applic...
Biogen (BIIB) is back in focus after the European Commission approved a high dose regimen of SPINRAZA for 5q spinal muscular atrophy. The decision expands the t...
Analyst ratings
51%
of 37 ratingsMore BIIB News
Biogen Inc. recently received European Commission marketing authorization for a new high dose regimen of SPINRAZA (nusinersen) to treat 5q spinal muscular atrop...
European Commission grants marketing authorization for a high dose regimen of SPINRAZA for 5q spinal muscular atrophy. The decision expands available treatment...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.